April 22, 2024
Navigating cancer: Understanding tumor grades and stages
UNC Health oncologists and pathologist provide a basic overview of staging cancers and grading tumors, and why these categories are important to your medical team.
Tag: Christopher Dittus
December 8, 2023
UNC researchers present latest findings at American Society of Hematology Annual Meeting
Researchers from UNC Lineberger and UNC will present findings from studies, speak at scientific symposia and lead educational sessions at the 65th American Society of Hematology Annual Meeting.
December 9, 2022
UNC Lineberger and UNC researchers discuss latest research at American Society of Hematology Annual Meeting
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.
October 22, 2021
Student-athlete raising awareness, funds for other young people with cancer
Emily Grund, a member of the UNC-Chapel Hill diving team, found support from friends, family and UNC Lineberger programs after being diagnosed with acute promyelocytic leukemia, a rare form of cancer.
May 11, 2021
Celebrating nearly 15 centuries of service
The University of North Carolina at Chapel Hill is recognizing 118 UNC Lineberger staff and faculty members who will be celebrating a service milestone this year.
January 8, 2021
Donors credit doctors for life-saving cancer care
Doug Wilson was treated for a rare form of non-Hodgkin lymphoma called mantle cell lymphoma. To give back to the doctors who treated his cancer, he created a fund to support their work in bone marrow transplants and the continued exploration of treatment options for mantle cell lymphoma.
January 14, 2020
Dittus and colleagues write the book on rare lymphomas
UNC Lineberger’s Christopher Dittus, DO, MPH, assistant professor of medicine at UNC School of Medicine, is the editor of a new book that provides a comprehensive review of how to diagnose and manage rare lymphomas, with a focus on novel treatment approaches. UNC Lineberger faculty and trainees contributed chapters to the volume. “Novel Therapeutics for …
December 3, 2018
Study shows promise for fighting relapsed blood cancer with CAR-T immunotherapy, chemotherapy
At the 60th American Society of Hematology Annual Meeting in San Diego on Monday, UNC Lineberger's Natalie Grover, MD, presented preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.